Skip to main content
Top
Published in: European Radiology 11/2006

01-11-2006 | Editorial

Molecular imaging in radiology: the latest fad or the new frontier?

Authors: Gabriel P. Krestin, Monique R. Bernsen

Published in: European Radiology | Issue 11/2006

Login to get access

Excerpt

Molecular imaging is “hot”. The past 5 years have seen a gradual increase in the number of publications on this topic in concert with the release of a number of specialized journals and the foundation of several “Molecular Imaging Institutes”. More papers utilizing (repeatedly) the term “Molecular Imaging” have been published in the last month than in the entire year 2000. What is all this commotion about? At a first glance it may seem to be a hype, with a lot of effort being put into formulating the right definition of what “Molecular Imaging” entails. Several renowned researchers have launched a definition that encompasses the visualization/characterization of biological processes in living organisms [1, 2]. However, at the April 2005 summit on molecular imaging organized by the Radiological Society of North America (RSNA) and the Society of Nuclear Medicine (SNM), a large panel of physicians and scientists, representing societies of biomedical imaging professionals and nuclear medicine specialists from around the world, agreed that the existing definitions do not fully cover the existing variety of imaging tools available in humans and in animals. In order to correct this deficit the group developed the following definition: “MI techniques directly or indirectly monitor and record the spatiotemporal distribution of molecular or cellular processes for biochemical, biologic, diagnostic, or therapeutic applications” [3, 4]. …
Literature
1.
go back to reference Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333PubMed Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333PubMed
2.
go back to reference Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580PubMedCrossRef Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580PubMedCrossRef
3.
go back to reference Thakur ML, Lentle BC (2005) SNM; Radiological Society of North America (RSNA). Joint SNM/RSNA Molecular Imaging Summit Statement. J Nucl Med 46:11N–13N 42N Thakur ML, Lentle BC (2005) SNM; Radiological Society of North America (RSNA). Joint SNM/RSNA Molecular Imaging Summit Statement. J Nucl Med 46:11N–13N 42N
4.
go back to reference Thakur M, Lentle BC (2006) Report of a summit on molecular imaging. AJR Am J Roentgenol 186:297–299PubMedCrossRef Thakur M, Lentle BC (2006) Report of a summit on molecular imaging. AJR Am J Roentgenol 186:297–299PubMedCrossRef
5.
6.
go back to reference Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat-Rev Cancer 2:683–693PubMedCrossRef Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat-Rev Cancer 2:683–693PubMedCrossRef
8.
go back to reference Bengel FM, Schachinger V, Dimmeler S (2005) Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging 32:S404–S416PubMedCrossRef Bengel FM, Schachinger V, Dimmeler S (2005) Cell-based therapies and imaging in cardiology. Eur J Nucl Med Mol Imaging 32:S404–S416PubMedCrossRef
9.
go back to reference Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRef Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491–2499PubMedCrossRef
10.
go back to reference Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507PubMedCrossRef Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507PubMedCrossRef
11.
go back to reference Van den Abbeele AD, Badawi RD (2002) Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 38:S60–S65PubMed Van den Abbeele AD, Badawi RD (2002) Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs). Eur J Cancer 38:S60–S65PubMed
12.
go back to reference Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM (2004) Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Nat Biotechnol 22:701–706PubMedCrossRef Smith-Jones PM, Solit DB, Akhurst T, Afroze F, Rosen N, Larson SM (2004) Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors. Nat Biotechnol 22:701–706PubMedCrossRef
13.
14.
go back to reference Fayad ZA (2003) MR imaging for the noninvasive assessment of atherothrombotic plaques. Magn Reson Imaging Clin N Am 11:101–113PubMedCrossRef Fayad ZA (2003) MR imaging for the noninvasive assessment of atherothrombotic plaques. Magn Reson Imaging Clin N Am 11:101–113PubMedCrossRef
Metadata
Title
Molecular imaging in radiology: the latest fad or the new frontier?
Authors
Gabriel P. Krestin
Monique R. Bernsen
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
European Radiology / Issue 11/2006
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0454-4

Other articles of this Issue 11/2006

European Radiology 11/2006 Go to the issue